Skip to content

Randomized Study of a Simple Weight Loss Program for Obese Patients With Obstructive Sleep Apnea

A Randomized Controlled Pilot Study of a Simple Weight Loss Program for Obese Patients With Mild to Moderate Obstructive Sleep Apnea

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00131547
Enrollment
56
Registered
2005-08-18
Start date
2004-09-30
Completion date
2007-08-31
Last updated
2008-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obstructive Sleep Apnea

Keywords

Obesity, Obstructive Sleep Apnea

Brief summary

The purpose of the study is to determine if weight loss interventions aimed at lifestyle modification (dietary education, food diary pedometer) result in weight loss in patients with mild-moderate obstructive sleep apnea (OSA) when compared to usual patient care. The secondary purpose of the study is to determine if the amount of weight loss achieved in a 6 month period results in improvements in snoring and other symptoms and in the frequency of apnea on overnight monitoring.

Detailed description

The purpose of the study is to determine if weight loss interventions aimed at lifestyle modification (dietary education, food diary pedometer) result in weight loss in patients with mild-moderate obstructive sleep apnea (OSA) when compared to usual patient care. The secondary purpose of the study is to determine if the amount of weight loss achieved in a 6 month period results in improvements in snoring and other symptoms and in the frequency of apnea on overnight monitoring. Primary Objective * To determine if weight loss interventions aimed at lifestyle modification (dietary education, food diary pedometer) result in weight loss in patients with mild-moderate OSA when compared to usual care. * To determine if the amount of weight loss achieved in a 6 month period result in improvements in objective measures of sleep disordered breathing (AHI). Secondary Objective * To determine if the weight loss achieved in 6 months result in improvements in OSA symptoms (e.g., snoring, sleepiness) and quality of life. * To determine if metabolic parameters (e.g., lipids, glucose) improve. * To determine if there is improvement in sleep structure and oxygenation during sleep.

Interventions

BEHAVIORALDietary Counseling

Dietary Counseling, use of a food diary and pedometer

Sponsors

Ontario Lung Association
CollaboratorOTHER
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients who have undergone a sleep study at the London Health Sciences Centre or St. Thomas Elgin General Hospital Sleep Laboratory and who are newly diagnosed with obstructive sleep apnea * Patients with an age over 18 years * Patients who have an apnea-hypopnea index (AHI) of 5-40 per hour (mild-to-moderate OSA) * Patients who have an elevated body mass index (BMI) of 28 to 39 kg/m2 * Patients who have an Epworth Sleepiness Scale score ≤11

Exclusion criteria

Patients will not be recruited: * if they are on weight loss medications * if they have seen a registered dietician in the preceding 6 months for dietary counseling * if they have attended a weight loss program in the last 6 months * if they have a history of a car accident related to sleepiness or report sleepiness when driving * if they work in a safety critical occupation and require treatment for work reasons * if they have serious or unstable cardiac co-morbidity * if they are unable or unwilling to provide informed consent * if they are pregnant * if they are unwilling to return for follow-up visits

Design outcomes

Primary

MeasureTime frame
Post treatment weight (kg)6 months

Secondary

MeasureTime frame
Quality of life (FOSQ)6 months
Excessive daytime sleepiness (ESS)6 months
Waist-hip ratio (WHR)6 months
Blood pressure6 months
Change in snoring (Visual analogue scale)6 months
Sleep fragmentation6 months
Oxygen saturation6 months
Post treatment AHI6 months
Lipid and glucose levels6 months

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026